Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 19/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7315875 | 1.00 | KIF11 (0.58) | KIF11CYP1A2CYP2C19HIF1A | |
| SCHEMBL7325113 | 0.88 | KIF11 (0.73) | KIF11CYP1A2CYP2C19HIF1A | |
| SCHEMBL7325122 | 0.88 | KIF11 (0.73) | KIF11CYP1A2CYP2C19HIF1A | |
| SCHEMBL7316099 | 0.87 | KIF11 (0.77) | KIF11CYP1A2CYP2C19HIF1A | |
| SCHEMBL7316096 | 0.87 | KIF11 (0.77) | KIF11CYP1A2CYP2C19HIF1A | |
| SCHEMBL7320873 | 0.87 | KIF11 (0.76) | KIF11CYP1A2CYP2C19HIF1A | |
| SCHEMBL7320878 | 0.87 | KIF11 (0.76) | KIF11CYP1A2CYP2C19HIF1A | |
| SCHEMBL7316483 | 0.86 | KIF11 (0.78) | KIF11CYP1A2CYP2C19HIF1A | |
| SCHEMBL7316488 | 0.86 | KIF11 (0.78) | KIF11CYP1A2CYP2C19HIF1A | |
| SCHEMBL7323248 | 0.78 | KIF11 (0.40) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999041227-A1 | TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS | ALLELIX NEUROSCIENCE, INC. (US) | 1999-08-19 | — | — | WO | claimed |
| US-6162824-A | NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | ALLELIX NEUROSCIENCE INC. | 2000-12-19 | — | — | US | disclosed |
| WO-1999041227-A1 | TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS | ALLELIX NEUROSCIENCE, INC. (US) | 1999-08-19 | — | — | WO | disclosed |